FDA Approves GABAPENTIN — Creekwood Pharmaceuticals LLC

# FDA Approves Generic Gabapentin from Creekwood Pharmaceuticals Creekwood Pharmaceuticals LLC has received FDA approval for its generic gabapentin oral formulation, expanding the competitive landscape in the neuropathic pain and seizure disorder markets and potentially lowering treatment costs for patients as additional generic alternatives enter the market. The approval of the ANDA application is expected to increase price competition in the gabapentin market, which has seen significant generic penetration since the original branded formulation's patent expiration.